questionsmedicales.fr
Système nerveux
Système nerveux central
Encéphale
Prosencéphale
Télencéphale
Cerveau
Cortex cérébral
Lobe temporal
Lobe temporal : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Lobe temporal : Questions médicales les plus fréquentes",
"headline": "Lobe temporal : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Lobe temporal : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-25",
"dateModified": "2025-03-20",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Lobe temporal"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Cortex cérébral",
"url": "https://questionsmedicales.fr/mesh/D002540",
"about": {
"@type": "MedicalCondition",
"name": "Cortex cérébral",
"code": {
"@type": "MedicalCode",
"code": "D002540",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.186.211.200.885.287.500"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Cortex auditif",
"alternateName": "Auditory Cortex",
"url": "https://questionsmedicales.fr/mesh/D001303",
"about": {
"@type": "MedicalCondition",
"name": "Cortex auditif",
"code": {
"@type": "MedicalCode",
"code": "D001303",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.186.211.200.885.287.500.863.297"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Cortex périrhinal",
"alternateName": "Perirhinal Cortex",
"url": "https://questionsmedicales.fr/mesh/D000071039",
"about": {
"@type": "MedicalCondition",
"name": "Cortex périrhinal",
"code": {
"@type": "MedicalCode",
"code": "D000071039",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.186.211.200.885.287.500.863.574"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Faisceau unciné",
"alternateName": "Uncinate Fasciculus",
"url": "https://questionsmedicales.fr/mesh/D000083382",
"about": {
"@type": "MedicalCondition",
"name": "Faisceau unciné",
"code": {
"@type": "MedicalCode",
"code": "D000083382",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.186.211.200.885.287.500.863.712"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Centre de Wernicke",
"alternateName": "Wernicke Area",
"url": "https://questionsmedicales.fr/mesh/D065813",
"about": {
"@type": "MedicalCondition",
"name": "Centre de Wernicke",
"code": {
"@type": "MedicalCode",
"code": "D065813",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.186.211.200.885.287.500.863.850"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Lobe temporal",
"alternateName": "Temporal Lobe",
"code": {
"@type": "MedicalCode",
"code": "D013702",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Stephan Schuele",
"url": "https://questionsmedicales.fr/author/Stephan%20Schuele",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology, Northwestern University, Feinberg School of Medicine, Neurological Testing Center, 251 East Huron Street, Galter Pavilion 7-104, Chicago, IL 60611, USA. Electronic address: s-schuele@northwestern.edu."
}
},
{
"@type": "Person",
"name": "Adam S Dickey",
"url": "https://questionsmedicales.fr/author/Adam%20S%20Dickey",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology, Emory University Hospital, Atlanta, GA, United States."
}
},
{
"@type": "Person",
"name": "Jon T Willie",
"url": "https://questionsmedicales.fr/author/Jon%20T%20Willie",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurosurgery, Emory University Hospital, Atlanta, GA, United States."
}
},
{
"@type": "Person",
"name": "Jeffrey R Binder",
"url": "https://questionsmedicales.fr/author/Jeffrey%20R%20Binder",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Giulia Maria Tallarita",
"url": "https://questionsmedicales.fr/author/Giulia%20Maria%20Tallarita",
"affiliation": {
"@type": "Organization",
"name": "Department of Diagnostics and Applied Technology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Prenatal diagnosis of fetuses conceived by assisted reproductive technology by karyotyping and chromosomal microarray analysis.",
"datePublished": "2023-01-17",
"url": "https://questionsmedicales.fr/article/36684682",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7717/peerj.14678"
}
},
{
"@type": "ScholarlyArticle",
"name": "Chromosome microarray analysis combined with karyotype analysis is a powerful tool for the detection in pregnant women with high-risk indicators.",
"datePublished": "2023-11-11",
"url": "https://questionsmedicales.fr/article/37951870",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12884-023-06052-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "Saliva DNA: An alternative biospecimen for single nucleotide polymorphism chromosomal microarray analysis in autism.",
"datePublished": "2023-09-15",
"url": "https://questionsmedicales.fr/article/37715344",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/ajmg.a.63400"
}
},
{
"@type": "ScholarlyArticle",
"name": "Fetal congenital gastrointestinal obstruction: prenatal diagnosis of chromosome microarray analysis and pregnancy outcomes.",
"datePublished": "2023-07-08",
"url": "https://questionsmedicales.fr/article/37422671",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12884-023-05828-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "Genetic causes of isolated and severe fetal growth restriction in normal chromosomal microarray analysis.",
"datePublished": "2023-01-02",
"url": "https://questionsmedicales.fr/article/36495297",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/ijgo.14620"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Système nerveux",
"item": "https://questionsmedicales.fr/mesh/D009420"
},
{
"@type": "ListItem",
"position": 3,
"name": "Système nerveux central",
"item": "https://questionsmedicales.fr/mesh/D002490"
},
{
"@type": "ListItem",
"position": 4,
"name": "Encéphale",
"item": "https://questionsmedicales.fr/mesh/D001921"
},
{
"@type": "ListItem",
"position": 5,
"name": "Prosencéphale",
"item": "https://questionsmedicales.fr/mesh/D016548"
},
{
"@type": "ListItem",
"position": 6,
"name": "Télencéphale",
"item": "https://questionsmedicales.fr/mesh/D013687"
},
{
"@type": "ListItem",
"position": 7,
"name": "Cerveau",
"item": "https://questionsmedicales.fr/mesh/D054022"
},
{
"@type": "ListItem",
"position": 8,
"name": "Cortex cérébral",
"item": "https://questionsmedicales.fr/mesh/D002540"
},
{
"@type": "ListItem",
"position": 9,
"name": "Lobe temporal",
"item": "https://questionsmedicales.fr/mesh/D013702"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Lobe temporal - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Lobe temporal",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Lobe temporal",
"description": "Comment diagnostiquer une lésion du lobe temporal ?\nQuels tests neurologiques sont utilisés pour évaluer le lobe temporal ?\nQuels signes cliniques indiquent un problème au lobe temporal ?\nLe lobe temporal peut-il être affecté par des infections ?\nComment évaluer la fonction auditive liée au lobe temporal ?",
"url": "https://questionsmedicales.fr/mesh/D013702?mesh_terms=Microarray+Analysis&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Lobe temporal",
"description": "Quels sont les symptômes d'une lésion du lobe temporal ?\nComment se manifestent les troubles du langage liés au lobe temporal ?\nLes troubles émotionnels peuvent-ils être liés au lobe temporal ?\nQuelles sont les crises épileptiques associées au lobe temporal ?\nLes troubles de la mémoire sont-ils spécifiques au lobe temporal ?",
"url": "https://questionsmedicales.fr/mesh/D013702?mesh_terms=Microarray+Analysis&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Lobe temporal",
"description": "Comment prévenir les lésions au lobe temporal ?\nLes habitudes de vie peuvent-elles influencer la santé du lobe temporal ?\nLe stress peut-il affecter le lobe temporal ?\nComment réduire le risque d'épilepsie temporale ?\nLes vaccinations peuvent-elles prévenir des infections cérébrales ?",
"url": "https://questionsmedicales.fr/mesh/D013702?mesh_terms=Microarray+Analysis&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Lobe temporal",
"description": "Quels traitements sont disponibles pour les lésions du lobe temporal ?\nComment traiter les crises épileptiques liées au lobe temporal ?\nLa rééducation est-elle nécessaire après une lésion du lobe temporal ?\nQuels médicaments sont utilisés pour les troubles de la mémoire ?\nLa chirurgie est-elle une option pour les tumeurs du lobe temporal ?",
"url": "https://questionsmedicales.fr/mesh/D013702?mesh_terms=Microarray+Analysis&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Lobe temporal",
"description": "Quelles complications peuvent survenir après une lésion du lobe temporal ?\nLes troubles de la mémoire peuvent-ils s'aggraver avec le temps ?\nLes crises épileptiques peuvent-elles entraîner des blessures ?\nComment les troubles émotionnels peuvent-ils évoluer ?\nLes tumeurs du lobe temporal peuvent-elles être mortelles ?",
"url": "https://questionsmedicales.fr/mesh/D013702?mesh_terms=Microarray+Analysis&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Lobe temporal",
"description": "Quels sont les facteurs de risque pour les lésions du lobe temporal ?\nL'âge influence-t-il le risque de troubles du lobe temporal ?\nLe sexe joue-t-il un rôle dans les troubles du lobe temporal ?\nLes antécédents d'épilepsie augmentent-ils le risque de lésions ?\nLe stress chronique est-il un facteur de risque pour le lobe temporal ?",
"url": "https://questionsmedicales.fr/mesh/D013702?mesh_terms=Microarray+Analysis&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une lésion du lobe temporal ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un IRM ou un scanner cérébral peut révéler des anomalies dans le lobe temporal."
}
},
{
"@type": "Question",
"name": "Quels tests neurologiques sont utilisés pour évaluer le lobe temporal ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de mémoire, d'audition et d'évaluation cognitive sont souvent utilisés."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent un problème au lobe temporal ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles de la mémoire, des crises épileptiques ou des difficultés de langage peuvent survenir."
}
},
{
"@type": "Question",
"name": "Le lobe temporal peut-il être affecté par des infections ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des infections comme l'encéphalite peuvent affecter le lobe temporal."
}
},
{
"@type": "Question",
"name": "Comment évaluer la fonction auditive liée au lobe temporal ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des audiogrammes et des tests d'audition peuvent évaluer la fonction auditive."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une lésion du lobe temporal ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des troubles de la mémoire, des hallucinations auditives et des crises."
}
},
{
"@type": "Question",
"name": "Comment se manifestent les troubles du langage liés au lobe temporal ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent se manifester par des difficultés à comprendre ou à produire des mots."
}
},
{
"@type": "Question",
"name": "Les troubles émotionnels peuvent-ils être liés au lobe temporal ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles émotionnels comme l'anxiété peuvent être associés à des dysfonctionnements."
}
},
{
"@type": "Question",
"name": "Quelles sont les crises épileptiques associées au lobe temporal ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les crises temporales peuvent inclure des automatisms et des altérations de la conscience."
}
},
{
"@type": "Question",
"name": "Les troubles de la mémoire sont-ils spécifiques au lobe temporal ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le lobe temporal joue un rôle clé dans la formation et le rappel des souvenirs."
}
},
{
"@type": "Question",
"name": "Comment prévenir les lésions au lobe temporal ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les traumatismes crâniens et gérer les infections peut aider à prévenir les lésions."
}
},
{
"@type": "Question",
"name": "Les habitudes de vie peuvent-elles influencer la santé du lobe temporal ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation saine et l'exercice régulier peuvent améliorer la santé cérébrale."
}
},
{
"@type": "Question",
"name": "Le stress peut-il affecter le lobe temporal ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut avoir des effets néfastes sur la fonction cérébrale."
}
},
{
"@type": "Question",
"name": "Comment réduire le risque d'épilepsie temporale ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les déclencheurs connus et suivre un traitement médical peut réduire le risque."
}
},
{
"@type": "Question",
"name": "Les vaccinations peuvent-elles prévenir des infections cérébrales ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines vaccinations peuvent prévenir des infections qui affectent le cerveau."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les lésions du lobe temporal ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la médication, la thérapie comportementale et la chirurgie."
}
},
{
"@type": "Question",
"name": "Comment traiter les crises épileptiques liées au lobe temporal ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les médicaments antiépileptiques sont souvent prescrits pour contrôler les crises."
}
},
{
"@type": "Question",
"name": "La rééducation est-elle nécessaire après une lésion du lobe temporal ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la rééducation peut aider à récupérer des fonctions cognitives et langagières."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont utilisés pour les troubles de la mémoire ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme les inhibiteurs de la cholinestérase peuvent être prescrits."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle une option pour les tumeurs du lobe temporal ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la chirurgie peut être nécessaire pour retirer des tumeurs ou des lésions."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après une lésion du lobe temporal ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des troubles cognitifs persistants et des crises récurrentes."
}
},
{
"@type": "Question",
"name": "Les troubles de la mémoire peuvent-ils s'aggraver avec le temps ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les troubles de la mémoire peuvent s'aggraver si la cause sous-jacente n'est pas traitée."
}
},
{
"@type": "Question",
"name": "Les crises épileptiques peuvent-elles entraîner des blessures ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les crises peuvent provoquer des chutes et des blessures physiques."
}
},
{
"@type": "Question",
"name": "Comment les troubles émotionnels peuvent-ils évoluer ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent s'aggraver sans traitement, entraînant des problèmes de santé mentale plus graves."
}
},
{
"@type": "Question",
"name": "Les tumeurs du lobe temporal peuvent-elles être mortelles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines tumeurs peuvent être agressives et mettre la vie en danger si non traitées."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les lésions du lobe temporal ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traumatismes crâniens, les infections et les antécédents familiaux de troubles neurologiques."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de troubles du lobe temporal ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de troubles cognitifs et de démence augmente avec l'âge."
}
},
{
"@type": "Question",
"name": "Le sexe joue-t-il un rôle dans les troubles du lobe temporal ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études montrent que les hommes peuvent être plus à risque de certaines conditions."
}
},
{
"@type": "Question",
"name": "Les antécédents d'épilepsie augmentent-ils le risque de lésions ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes ayant des antécédents d'épilepsie sont à risque accru de lésions cérébrales."
}
},
{
"@type": "Question",
"name": "Le stress chronique est-il un facteur de risque pour le lobe temporal ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut contribuer à des troubles neurologiques et cognitifs."
}
}
]
}
]
}
Invasive prenatal evaluation by chromosomal microarray analysis (CMA) and karyotyping might represent an important option in pregnant women, but limited reports have applied CMA and karyotyping of fet...
This retrospective study included all singleton fetuses conceived by ART from January 2015 to December 2021. Anomalies prenatally diagnosed based on karyotyping and CMA were analyzed. Prevalence rates...
In total, 224 subjects were assessed by karyotyping and CMA. In the examined patients, chromosomal and karyotype abnormality rates were 3.57% (8/224) and 8.93% (20/224), respectively. This finding ind...
Prenatal diagnosis including karyotyping and CMA is recommended for fetuses conceived by ART, with or without ultrasound findings....
Karyotype analysis and fluorescence in situ hybridization (FISH) are commonly used for prenatal diagnosis, however they have many disadvantages. Chromosome microarray analysis (CMA) has the potential ...
A total of 3336 samples of amniotic fluid or umbilical cord blood from pregnant women with high-risk indicators at our center in southwest of China from June 2018 to January 2023 were included in the ...
3336 samples divided into 2911 cases with single and 425 cases with multiple high-risk indicators. The aneuploidy and pathogenic/likely pathogenic copy number variations (CNVs) of 2911 cases with sing...
The combined application of CMA and karyotyping were recommended in prenatal diagnosis for providing a scientific and accurate genetic diagnosis and improving the quality of prenatal genetic counselin...
Chromosomal microarray analysis (CMA) is typically performed for investigation of autism using blood DNA. However, blood collection poses significant challenges for autistic children with repetitive b...
The aim of this study was to investigate the incidence of chromosome anomalies in different types of congenital gastrointestinal obstruction and assess pregnancy outcomes of fetuses with congenital ga...
A total of 64 cases with gastrointestinal obstruction between January 2014 and December 2020 were enrolled in this study. They were divided into three groups according to sonographic images. Group A: ...
From January 2014 to December 2020, there were 64 fetus with congenital gastrointestinal obstruction underwent chromosome microarray analysis(CMA), the overall detection rate of CMA testing was 14.1%(...
It is crucial to understand whether the gastrointestinal tract abnormality is isolated or associated to other findings. The risk of chromosomal abnormalities in fetuses with isolated lower gastrointes...
To investigate the genetic burden in fetuses with isolated and severe fetal growth restriction (FGR) using Trio whole-exome sequencing (WES) with a normal chromosomal microarray....
This retrospective study analyzed WES results of singleton fetuses with isolated and severe FGR, whose estimated fetal weight (EFW) was less than the third percentile by Hadlock formula, in a tertiary...
Fifty-one fetuses with isolated and severe FGR and negative CMA results underwent Trio-WES. Of all patients, eight (15.7%) were diagnosed with FGR at its early onset (<32 weeks) and showed pathogenic ...
The present study indicates that Trio-WES can improve effectivity of prenatal diagnoses for isolated and severe FGR in cases with normal CMA results, aiding prenatal genetic counseling and pregnancy m...
Several studies have reported an association between residential surrounding particulate matter with an aerodynamic diameter ≤2.5 μm (PM...
To explore the prenatal clinical utility of chromosome microarray analysis (CMA) for polyhydramnios and evaluate the short and long-term prognosis of fetuses with polyhydramnios....
A total of 600 singleton pregnancies with persistent polyhydramnios from 2014 to 2020 were retrospectively enrolled in this study. All cases received amniocentesis and were subjected to CMA results. A...
The detection rates of either aneuploidy or pathogenic copy number variants in fetuses with non-isolated polyhydramnios were significantly higher than those with isolated polyhydramnios (5.0...
For low-risk pregnancies, invasive prenatal diagnosis of isolated polyhydramnios might be unnecessary. CMA should be considered for fetuses with structural anomalies. In CMA-negative cases, the progno...
To evaluate if the NT value of 2.5 mm ≤ NT < 3.0 mm is an appropriate indication for CMA tests among fetuses with isolated increased NT and NIPT is more suitable instead....
A total of 442 fetuses with NT ≥ 2.5 mm were included, in which 241 fetuses underwent karyotype. CMA tests were then carried out when cytogenic analysis showed normal chromosomes and CNV status was co...
Of the 241 fetuses with NT ≥ 2.5 mm, 47(19.50%) were identified by karyotype with chromosomal abnormalities. Among 194 cases with normal karyotype, CMA unraveled additional CNVs in 16(8.25%) cases, in...
While no pathogenic CNVs were detected in fetuses, chromosomal aneuploidies and genomic imbalance were found to be the major type of abnormalities when NT was 2.5-3.0 mm. Therefore, our data suggested...
Diabetic nephropathy (DN), which is the main cause of renal failure in end-stage renal disease, is becoming a common chronic renal disease worldwide. Mendelian randomization (MR) is a genetic tool tha...
Five DN gene expression datasets were selected from the Gene Expression Omnibus. The robust rank aggregation (RRA) method was used to integrate differentially expressed genes (DEGs) of glomerular samp...
A total of 82 DEGs (53 upregulated and 29 downregulated) were identified through RRA integrated analysis. The enriched Gene Ontology annotations and Kyoto Encyclopedia of Genes and Genomes pathways of...
Our integrated analysis identified novel biomarkers, including MICB and GZMA, which may help further understand the complicated mechanisms of DN and identify new target pathways for intervention....
Fetal hyperechogenic kidneys (HEK) is etiologically a heterogeneous disorder. The aim of this study was to identify the genetic causes of HEK using prenatal chromosomal microarray analysis (CMA) and e...